Apellis Pharmaceuticals raised $33M Series C venture round, led by AJU IB Investment.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
Epidarex CapitalLEAD | Venture Capital | — |
MorningsideLEAD | Private | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$140.1M
Top Valuation
-
Apellis Pharmaceuticals raised $33M in a Series C round.
The round was announced on 12/02/14.
The round was led by AJU IB Investment, Epidarex Capital, Gerald Chan.